MedPath

Optimizing hyperglycaemia management in the Acute Medical Unit: investigation of barriers to achieving adequate glucose control in patients with diabetes in the acute medical setting; introduction and evaluation of tools to assist clinicians in prescribing insuli

Recruiting
Conditions
diabetes
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12616001147471
Lead Sponsor
Dr Anne Corbould
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
400
Inclusion Criteria

The group of patients will be disparate, reflecting real-world clinical practice i.e. inclusion criteria will be broad:
Patients requiring subcutaneous insulin on admission to AMU – whether or not previously treated with insulin
Patients with known diabetes (Type 1/Type 2) or no previous diagnosis of diabetes.
Duration of admission 48 hours or greater.

Hospital staff to be included in the survey of knowledge/attitudes regarding inpatient diabetes management are: interns and resident medical officers who work in the AMU on rotation, consultant physicians who are permanently based in the AMU, and nursing staff who are permanent AMU staff and also on rotation in the AMU.

Exclusion Criteria

Patients admitted with diabetic ketoacidosis
Patients who are not eating and/or requiring intravenous insulin
Patients whose prognosis is so poor that management of hyperglycaemia is not indicated.

Exclusion criteria for hospital staff are speciality junior medical staff and consultant physicians whose patients are occupying an AMU bed, but are not cared for by the AMU medical staff.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint will be blood glucose levels pre- and post-implementation of the insulin management protocol. The results of mean blood glucose levels at fasting, nonfasting (i.e. pre-lunch, pre-evening meal and bedtime) per day of admission and mean glucose levels (mean of all glucose levels during the hospital stay) will be compared. This is a composite primary outcome. Blood glucose levels are assessed using a blood glucose meter. [Data from 6 months prior to intervention: and from 3 and 6 months post-intervention.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath